TCG Crossover Management, LLC
Q1 2025 13F Holdings
- Locationpalo alto, CA
- Num holdings
38
- Value ($000)
$1,466,171
- Date Filed05/14/2025
- Form type13F-HR
- CIK0001839948
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
CGON CG ONCOLOGY INC | COMM | 156944100 | $179.77 M | 25 % | 7,340,412 | ||
COGT COGENT BIOSCIENCES INC | COMM | 19240Q201 | $83.43 M | 11 % | 13,928,750 | ||
CNTA CENTESSA PHARMACEUTICALS PLC | ADRS | 152309100 | $83.14 M | 11 % | 5,781,632 | ||
MLYS MINERALYS THERAPEUTICS INC | COMM | 603170101 | $78.46 M | 11 % | 4,940,530 | ||
OCUL OCULAR THERAPEUTIX INC | COMM | 67576A100 | $77.98 M | 11 % | 10,638,296 | ||
ABIVAX SA AMERICAN DEPOSITARY SHARES | ADRS | 00370M103 | $75.71 M | 10 % | 12,113,192 | ||
YB4P SAVARA INC | COMM | 805111101 | $68.49 M | 9 % | 24,724,410 | ||
DYN DYNE THERAPEUTICS INC | COMM | 26818M108 | $55.44 M | 8 % | 5,300,300 | ||
DNTH DIANTHUS THERAPEUTICS INC | COMM | 252828108 | $54.48 M | 7 % | 3,003,248 | ||
TYRA BIOSCIENCES INC | COMM | 90240B106 | $53.90 M | 7 % | 5,796,206 |
Rows Per Page
10
- 10
- 50
- 100